Trial
NCT04661033
Safety, Pharmacokinetics, and Efficacy of Subcutaneous Isatuximab in Adults With Warm Autoimmune Hemolytic Anemia (wAIHA)
Phase IITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
Sanofi
Collaborators
—
Condition
Warm Autoimmune Hemolytic Anemia (wAIHA)
Intervention
Isatuximab SAR650984
Why stopped
Study discontinuation based on strategic sponsor decision; not driven by any safety concerns.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2024-12-05